Component: (Network and Table) | |
---|---|
Network |
1005000 - Statement - Statements of Cash Flow
(http://www.sequans.com/role/StatementsOfCashFlow) |
Table | (Implied) |
Reporting Entity [Axis] | 0001383395 (http://www.sec.gov/CIK) |
Statement of cash flows [abstract] | Period [Axis] | ||
---|---|---|---|
2017-01-01 - 2017-12-31 |
2016-01-01 - 2016-12-31 |
2015-01-01 - 2015-12-31 | |
Statement of cash flows [abstract] |
|
|
|
Operating activities: |
|
|
|
Profit (Loss) before income taxes |
(25,860,000) |
(24,503,000) |
(27,085,000) |
Non-cash adjustment to reconcile income (loss) before tax to net cash used in operating activities: |
|
|
|
Amortization and impairment of property, plant and equipment |
|
|
|
Amortization and impairment of intangible assets |
|
|
|
Share-based payment expense |
|
|
|
Increase (Decrease) in provisions |
|
( |
|
Interest expense, net |
|
|
|
Convertible debt amendments |
|
|
|
Change in fair value of convertible debt embedded derivative |
|
|
|
Other financial expenses |
|
|
|
Foreign exchange loss (gain) |
|
( |
( |
Loss on disposal of property, plant and equipment |
|
|
|
Working capital adjustments: |
|
|
|
Decrease (Increase) in trade receivables and other receivables |
( |
|
( |
Decrease (Increase) in inventories |
|
( |
|
Decrease (Increase) in research tax credit receivable |
( |
|
|
Increase (Decrease) in trade payables and other liabilities |
( |
|
|
Increase (Decrease) in deferred revenue |
( |
( |
|
Decrease in government grant advances |
( |
( |
( |
Income tax paid |
( |
( |
( |
Net cash flow used in operating activities |
(
|
(
|
(
|
Investing activities: |
|
|
|
Purchase of intangible assets and property, plant and equipment |
( |
( |
( |
Capitalized development expenditures |
( |
( |
( |
Sale (Purchase) of financial assets |
( |
|
|
Increase (Decrease) of short-term deposit |
( |
|
( |
Interest received |
|
|
|
Net cash flow used in investments activities |
(
|
(
|
(
|
Financing activities: |
|
|
|
Public equity offering proceeds, net of transaction costs paid |
|
|
|
Proceeds from issue of warrants and exercise of stock options/warrants, net of transaction costs |
|
|
|
Proceeds (repayment of) from interest-bearing receivables financing |
( |
|
|
Proceeds from interest-bearing research project financing |
|
|
|
Proceeds from government loans, net of transaction cost |
|
|
|
Proceeds from convertible debt, net of transaction cost |
|
|
|
Repayment of government loans |
( |
|
|
Repayment of borrowings and finance lease liabilities |
|
( |
( |
Interest paid |
( |
( |
( |
Net cash flows from financing activities |
|
|
|
Net increase (decrease) in cash and cash equivalents |
(
|
|
(
|
Net foreign exchange difference |
|
( |
( |
Cash and cash equivalent at January 1 |
20,202,000 |
8,288,000 |
|
Cash and cash equivalents at period end |
2,948,000
|
20,202,000
|
8,288,000
|